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ABSTRACT  
 
Previous studies suggest that male testosterone concentrations have declined over time. To 
explore this in a large US population, we examined testosterone and free testosterone 
concentrations in National Health and Nutrition Examination Surveys (NHANES) from 1988-
1991 and 1999-2004. We also examined sex hormone-binding globulin (SHBG), estradiol, and 
androstanediol glucuronide (3α-diol-G) over the same period. Non-Hispanic white, non-Hispanic 
black, and Mexican-American men from 1988-1991 and 1999-2004 NHANES surveys who were 
≥ 20 years old and had serum from morning blood draws were included in this analysis (1988-
1991: N=1,413; 1999-2004: N=902). Testosterone, estradiol, and SHBG were measured by 
competitive electrochemiluminescence immunoassays and 3α-diol-G was measured by enzyme 
immunoassay. Free testosterone was calculated using testosterone and SHBG values. Adjusted 
mean hormone concentrations were estimated using linear regression, accounting for NHANES 
sampling weights and design, age, race/ethnicity, body mass index, waist circumference, alcohol 
use, and smoking. Differences in adjusted mean concentrations (Δ) and two-sided P-values were 
calculated; P<0.05 was statistically significant. Overall, 3α-diol-G and estradiol declined 
between 1988-1991 and 1999-2004, but there was little change in testosterone, free testosterone, 
or SHBG (Δ: 3α-diol-G =-1.83 ng/mL, P<0.01; estradiol=-6.07 pg/mL, P<0.01; testosterone=-
0.03 ng/mL, P=0.75; free testosterone=-0.001 ng/mL, P=0.67; SHBG=-1.17 nmol/L, P=0.19). 
Stratification by age and race revealed that SHBG and 3α-diol-G declined among whites 20-44 
years old (Δ: SHBG=-5.14 nmol/L, P<0.01; 3α-diol-G =-2.89 ng/mL, P<0.01) and free 
testosterone increased among blacks 20-44 years old (Δ: 0.014, P=0.03). Estradiol declined 
among all ages of whites and Mexican-Americans. In conclusion, there was no evidence for 
testosterone decline between 1988-1991 and 1999-2004 in the US general population. Subgroup 
analyses suggest that SHBG and 3α-diol-G declined in young white men, estradiol declined in 
white and Mexican-American men, and free testosterone increased in young black men. These 
changes may be related to the increasing prevalence of reproductive disorders in young men. 
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INTRODUCTION 
Reports in the literature suggest that there have been declines in male reproductive health, 
including lower sperm quality and higher rates of cryptorchidism, hypospadias, and testicular 
germ cell tumors (TGCTs), collectively referred to as testicular dysgenesis syndrome (TDS) 
(James 2010; Skakkebaek et al. 2001). It has been hypothesized that TDS may involve reduced 
testosterone concentrations, due to malformation and improper functioning of Leydig cells in the 
testes (Skakkebaek et al. 2001). Murine models have reported that in utero exposure of male 
fetuses to chemicals that produce the physiologic hallmarks of TDS results in lower testicular 
testosterone concentrations in the fetus, but normal plasma testosterone concentrations in 
adulthood (Fisher et al. 2003; Mahood et al. 2005; Mahood et al. 2007). Whether a link exists 
between testosterone concentrations and reproductive abnormalities in humans is unclear. Nor 
has it been established whether population testosterone concentrations in humans have declined. 
Despite the increasing interest in secular declines in male hormone concentrations, only 
two epidemiological studies have evaluated changes in male testosterone concentrations over 
time. Among Danish men who participated in studies between 1982 and 2001, there was no 
significant change in testosterone concentration over time after adjustment for body mass index 
(BMI) (Andersson et al. 2007). Higher BMI is associated with lower testosterone concentrations 
(Macdonald et al. 2010), and population increases in BMI may have been an underlying cause of 
the decline in testosterone. However, a study of US men, the Massachusetts Male Aging Study 
(MMAS), reported that testosterone declined among men followed from 1987-1989 to 2002-
2004, even after adjustment for BMI and other factors (Travison et al. 2007).  
The question of whether male testosterone levels have declined over time remains 
unanswered due to the conflicting results from Andersson et al. (Andersson et al. 2007) and 
Travison et al. (Travison et al. 2007). Additionally, the population studied by Travison et al. was 
drawn from a narrowly-defined geographic area, and it is not clear if the results can be 
extrapolated to the broader U.S. population. Therefore, we compared concentrations of 
testosterone and free testosterone in men from the 1988-1991 and 1999-2004 National Health 
and Nutrition Examination Surveys (NHANES), nationally representative cross-sectional studies 
in the US. We also examined concentrations of estradiol, sex hormone-binding globulin (SHBG), 
and androstanediol glucuronide (3α-diol-G). SHBG is a carrier protein that binds testosterone 
and estradiol, and 3α-diol-G, a metabolite of dihydrotestosterone (DHT), is correlated with tissue 
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androgen concentrations. TGCTs occur predominantly among men 20-44 years old and are more 
common among white than non-white men (Bray et al. 2006; Mcglynn et al. 2003), leading us to 
hypothesize that if changes in male hormones were related to TDS, these changes might be most 
evident in young white men. To explore this hypothesis, we examined changes in hormones by 
race/ethnicity and age. 
 
MATERIALS AND METHODS 
Study Population 
National Health and Nutrition Examination Survey 
NHANES is a series of cross-sectional surveys conducted by the Centers for Disease 
Control and Prevention (CDC) in order to assess the health and nutrition status of Americans 
(Http://Www.Cdc.Gov/Nchs/Nhanes.Htm). Participant sampling follows a complex stratified, 
multistage, probability-cluster design in order to select a representative sample of the civilian, 
non-institutionalized US population based on age, gender, and race/ethnicity. Participants are not 
followed longitudinally. Therefore, participants in the 1999-2004 survey were not the same 
individuals as the participants in the 1988-1991 survey. The survey interview includes 
demographic, socioeconomic, and health-related questions. The examination component consists 
of laboratory tests, medical and physiological measurements, and blood collection. Once routine 
testing of blood samples is completed, the CDC allows investigators to access surplus sera for 
approved scientific studies.  
In this study, we estimated hormone concentrations for non-Hispanic white (hereafter 
referred to as white), non-Hispanic black (hereafter referred to as black), and Mexican-American 
men only. Other racial/ethnic groups were excluded due to small sample sizes. 
Protocols for the 1988-1991 and 1999-2004 NHANES surveys were conducted in 
accordance with the Declaration of Helsinki and were approved by the Ethics Review Board of 
the National Center for Health Statistics (NCHS), U.S. Centers for Disease Control and 
Prevention. Documented informed consent was obtained from all participants. Measurement of 
sex steroid hormones was approved by the National Institutes of Health Office of Human 
Subjects Research and the National Center for Health Statistics Ethics Review Board. 
 
NHANES 1988-1991  
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Characteristics of the 1988-1991 survey participants and their mean hormone 
concentrations were reported previously (Rohrmann et al. 2007). Briefly, there were 4,227 male 
participants who were at least 20 years old at the time of interview. 4,122 of these men 
participated in the examination, of whom 2,009 participated in the morning examination. Of 
these men, 1,470 had surplus serum samples available for analysis. The 1988-1991 analytic 
population included the 1,413 participants who were white (N=674), black (N=363), or Mexican 
American (N=376) (supplementary figure).  
 
NHANES 1999-2004  
There were 15,184 male participants in the 1999-2004 surveys; 7,223 were aged 20 years 
or older. A total of 6,735 of these men participated in the examination, of whom 3,281 
participated in the morning examination. Hormone concentrations were examined within a one-
third, stratified random sample of participants that had already been selected for a study of serum 
organochlorine concentrations. A total of 1,085 men who attended the morning exam were in this 
subsample, of whom 985 had surplus serum available for analysis. The 1999-2004 analytic 
population included the 902 men who were white (N=503), black (N=183) or Mexican American 
(N=216) (supplementary figure). 
 
Hormone Measurement 
Serum was separated from blood obtained during the NHANES examination and stored 
at -80°C. For 1988-1991 survey participants, testosterone, estradiol, and SHBG were measured 
using the Elecsys 2010 system (Roche Diagnostics, Laval, QC, Canada) and 3α-diol-G was 
measured using the DSL-10-9200 ACTIVE® Androstanediol Glucuronide EIA kit (Diagnostic 
Systems Laboratories, Webster, TX) in the laboratory of Dr. Nader Rifai (Children’s Hospital, 
Boston, MA). Laboratory methods and quality control statistics were reported previously 
(Rohrmann et al. 2007).  
Serum testosterone, estradiol, 3α-diol-G, and SHBG concentrations for 1999-2004 survey 
participants were measured in the same laboratory. Testosterone, estradiol, and SHBG were 
measured using the Elecsys 2010 system. 3α-diol-G was measured by enzyme immunoassay 
using the Direct 3α Diol-G ELISA kit (ALPCO Diagnostics, Salem, NH). A subset of 21 1999-
2004 samples was assayed in duplicate to assess reproducibility. Coefficients of variation (CVs) 
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were 4.8% for testosterone, 5.6% for SHBG, 9.7% for 3α-diol-G, and 21.4% for estradiol. 
To examine the comparability of assays conducted for the two analysis populations, 
serum from 1988-1991 participants was retrieved from storage and re-assayed at the same time 
as the 1999-2004 samples. CVs for 1988-1991 samples assayed at both time points were 6.3% 
for testosterone, 5.3% for SHBG, 35.0% for 3α-diol-G, and 15.3% for estradiol. The higher CV 
for 3α-diol-G was likely due to the change in assay kit. The DSL-10-9200 EIA kit, used for 
samples from the 1988-1991 survey, was discontinued; 1999-2004 samples were assayed using 
the Direct 3α-diol-G ELISA kit.  
3α-diol-G concentrations were on average 21% lower when measured with the Direct 3α-
diol-G ELISA kit compared to the DSL-10-9200 EIA kit. Using the repeated sample data, a 
regression equation was formulated to account for the shift in values, similar to methods used for 
the analysis of vitamin D concentrations in NHANES (National Center for Health Statistics, 
2010). All 3α-diol-G concentrations for 1999-2004 participants were adjusted using this 
equation: 
 
3α-diol-G1999-2004 adjusted=0.68579 + 1.30589*3α-diol-G1999-2004 measured 
  
 Free testosterone was calculated using the testosterone and SHBG values, according to 
the method described by Vermeulen et al. (Vermeulen et al. 1999). 
 
Statistical Analysis 
Covariates 
Age, race/ethnicity, cigarette smoking, and alcohol use were self-reported in the 
NHANES interviews. Never smokers were defined as men who smoked fewer than 100 
cigarettes during their lifetimes. Former smokers were defined as men who smoked at least 100 
cigarettes in their lifetimes but now smoked “not at all”. Current smokers were defined as men 
who smoked at least 100 cigarettes in their lifetimes and currently smoked “every day” or “some 
days”. Men who drank fewer than 12 drinks annually were classified as having 0 drinks per 
week. Waist circumference, height, and weight were measured during the examination, and BMI 
(kg/m2) was calculated from height and weight. Percent body fat was calculated from height, 
weight, and bioelectrical impedance analysis (BIA) (Chumlea et al. 2002), however, in 1999-
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2004 BIA was performed only on participants younger than 50 years old who weighed less than 
300 pounds. Physical activity was not included as a covariate due to differences in the way 
variables were coded in the 1988-1991 and 1999-2004 surveys. 
 
Analysis 
Mean hormone concentrations and 95% confidence intervals (CIs) were estimated using 
linear regression, accounting for NHANES sampling weights and the complex sample design. 
Estradiol, 3α-diol-G, SHBG, and free testosterone concentrations were log-transformed because 
their sample distributions were skewed; geometric means were estimated and back-transformed 
for presentation. The distribution of testosterone was approximately normal, thus testosterone 
concentrations were not transformed for analysis.  
Adjusted means were estimated using predicted margins with several linear regression 
models. First, mean hormone concentrations were adjusted for the age (1-year intervals) and 
race/ethnicity distribution of the combined (1988-1991 and 1999-2004) population. In the second 
model, means were adjusted for age, race/ethnicity, BMI, waist circumference, alcohol use, and 
smoking.  
All regression models incorporated variables indicating sampling weights, stratification 
and clustering. Although the number of men included in the analysis is a small proportion of the 
total number of males interviewed for each NHANES survey, the analytic sample was derived 
from a series of random subsamples and is representative of the larger survey population. 
Sampling weights are specifically designed by the NCHS to account for this sampling process 
such that subsample estimates using the sampling weights are representative of the estimates that 
would have been obtained from larger NHANES survey population. Thus, mean hormone 
concentrations reflect population-level estimates. 
Sensitivity analyses were conducted to investigate the effect of adjusting for additional 
factors that may have influenced hormone concentrations. To determine the effect of adjusting 
for percent body fat instead of BMI, we estimated mean hormone concentrations adjusted for 
age, race/ethnicity, waist circumference, alcohol use, smoking and either percent body fat or 
BMI among men younger than 50 years old. To examine the influence of BMI outliers, we 
estimated change in hormone concentrations after excluding men with BMI in the lowest and 
highest 5% of the distribution; the lowest and highest 5% was determined separately for each 
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race/ethnicity group. To determine the effect of co-morbidities on mean hormone concentrations, 
models were additionally adjusted for self-reported history of arthritis, stroke, diabetes, 
osteoporosis, heart attack, heart failure and general health status. Variables were added 
individually to a regression model that adjusted for age, race/ethnicity, waist circumference, 
alcohol use, smoking and BMI. To evaluate whether the use of medications affected the 
difference in hormone concentrations between the two survey populations, we estimated mean 
hormone concentrations using regression models that additionally adjusted for recent use of 
selected medications. During the NHANES interview, men were asked if they had taken any 
medications in the past month for which a doctor’s or dentist’s prescription was needed; if they 
answered yes, they were asked the name of the medication. We identified the following 
medications that may affect sex hormone levels from the NHANES prescription drug file: 
finasteride, testosterone, flutamide, atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, 
and simvastatin. Overall, there were 14 individuals in the 1988-1991 analytic population and 52 
men in the 1999-2004 analytic population who reported taking at least one of these medications 
in the month before the survey. 
Differences in mean hormone concentrations were calculated by subtracting the 1988-
1991 means from the 1999-2004 means. Two-sided P-values for differences in means were 
calculated from ANOVA analyses; P-values less than 0.05 were considered statistically 
significant. Analyses were conducted using SUDAAN, v10.0 (RTI International, Research 
Triangle Park, NC) and SAS v9.1 (SAS, Cary, NC). 
 
RESULTS 
Participant characteristics 
The 1,413 1988-1991 NHANES participants, had a median age of 46 years and 49% were 
white (table 1). The median BMI among the participants was 25.8 kg/m2, the median waist size 
was 94.5 cm, and the median body fat percentage was 25.9. Most men (70%) were not current 
smokers and 38% did not drink alcohol.   
The 902 1999-2004 NHANES participants had a median age of 48 years and 57% were 
white (table 1). The median BMI was 27.3 kg/m2 and the median percentage of body fat among 
men younger than 50 years old was 24.6%. Median waist size was smallest among participants 
aged 20-44 years (94 cm) and largest among participants aged 45-69 years (103 cm). Younger 
 9  
participants were more commonly never-smokers and older participants were more commonly 
former smokers. Thirty percent of participants abstained from alcohol.  
 
Differences in hormone concentrations between 1988-1991 and 1999-2004 
Differences in mean hormone concentrations were first estimated adjusted only for age 
and race/ethnicity. These minimally adjusted models showed significant declines in mean 
concentrations of testosterone, free testosterone, SHBG, 3α-diol-G, and estradiol between 1988-
1991 and 1999-2004 (testosterone, P<0.01; free testosterone, P=0.02; SHBG, P<0.01; 3α-diol-G, 
P<0.01; estradiol, P<0.01; supplementary table 1). However, when models were fully adjusted 
for the additional covariates BMI, waist size, smoking, and alcohol consumption, there were no 
significant differences in testosterone, free testosterone, or SHBG concentrations (all P>0.05, 
table 2). The fully adjusted models continued to show significant declines in mean 3α-diol-G and 
estradiol (both P < 0.01; table 2).   
Stratification by age suggested that changes in some hormone concentrations occurred 
mainly in younger men. There were significant declines in SHBG (P<0.01) and 3α-diol-G 
(P<0.01) among men 20-44 years old, but not among men 45 and older (table 3). In contrast, 
SHBG concentrations increased in men 45-69 years old (P=0.04) and estradiol declined in men 
of all ages (table 3). There were no changes in testosterone or free testosterone for any age 
group. 
Differences in hormone concentrations also varied by race/ethnicity. Mean 3α-diol-G and 
estradiol concentrations declined significantly among white and Mexican-American men (3α-
diol-G, white P<0.01, Mexican-American P=0.03; estradiol, white P<0.01, Mexican-American 
P<0.01), but not black men (table 4). On the contrary, testosterone (P=0.02) and free testosterone 
(P=0.04) concentrations increased among black men, but not among white or Mexican-American 
men (table 4). 
Cross-stratification by age and race/ethnicity further suggested that changes in hormone 
profiles varied in the population. Significant declines in SHBG and 3α-diol-G were limited to 20-
44 year-old white men (SHBG P<0.01; 3α-diol-G P<0.01; table 5). Though concentrations of 3α-
diol-G tended to be lower in 1999-2004 among all age groups of Mexican-American men, the 
differences were not statistically significant after age stratification. There were significant 
declines in estradiol in all age groups of white and Mexican-American men, but not among black 
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men of any age (table 5). The increase in free testosterone concentration that was observed 
among black men was restricted to the youngest and oldest age groups (table 5). Testosterone 
levels also appeared higher among black men 20-44 and ≥ 70 years old, but did not reach 
statistical significance. 
 
Sensitivity analyses 
We explored whether the observed changes in hormone concentrations were due to 
changes in the prevalence of obesity. Differences in hormone concentrations among young men 
were similar for models that adjusted for percent body fat rather than BMI (data not shown). 
When we restricted the analyses to young white men with BMI between the 5th and 95th 
percentiles (20.4 to 36.6 kg/m2) the magnitude of decline for testosterone and SHBG diminished; 
the decline in SHBG was no longer statistically significant, but declines in 3α-diol-G and 
estradiol were still present (supplementary table 5). We also examined whether increases in 
testosterone and free testosterone in black men were affected by extreme BMIs. Among black 
men with BMIs between the 5th and 95th percentiles (19.2 to 37.6 kg/m2), increases in 
testosterone and free testosterone were essentially unchanged from the what was observed in the 
full population (supplementary table 6). Additional adjustment for co-morbidities, general health, 
or medication use did not change the results for comparisons in the overall population or within 
age or race/ethnicity-stratified groups (data not shown).  
 
DISCUSSION  
Our examination of sex hormone concentrations among US males during 1988-1991 and 
1999-2004 found that after adjustment for covariates there were declines in 3α-diol-G and 
estradiol, but not testosterone, free testosterone, or SHBG. Stratified analyses revealed declines 
in 3α-diol-G and SHBG concentrations among 20-44 year old white men. Although testosterone 
was lower among young white men, the decline was not significant, and sensitivity analyses 
showed that much of the difference was driven by men with extreme BMIs. Though there was no 
change in testosterone or free testosterone the overall population, we found that there were 
increases in both among black men. Comparisons among this subgroup were limited by small 
sample size, especially when also stratified by age, but the results were robust to the influence of 
extreme BMIs in the population. Replication in another population is needed to confirm this 
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result, but these data suggest that changes in hormones over time vary by age and race/ethnicity 
group. 
The lack of decline in testosterone and free testosterone in the NHANES population is in 
agreement with the results of Andersson et al. (Andersson et al. 2007), who found no decline in 
testosterone or free testosterone in Danish men after adjusting for BMI, suggesting that the 
decline they observed in unadjusted analyses was confounded by changes in body size. Our 
results do not agree with those from Travison et al. (Travison et al. 2007), which reported 
testosterone declines in unadjusted and adjusted analyses.  
Reasons for the discrepancy between our study and that of Travison et al. (Travison et al. 
2007) are not clear. The study populations were similar in terms of calendar time - NHANES and 
MMAS surveys were both conducted between the late 1980s to early 2000s, so differences 
between the two are not due to analysis of change in hormones concentrations over different 
lengths of time. Furthermore, although the MMAS involved predominantly white men and 
NHANES included multiple racial groups, there was still no decline in testosterone when 
NHANES analyses were limited to white men.  
One potential reason for the difference between these two US studies could be a 
difference in the prevalence of confounders. Factors such as age, body size, smoking, alcohol 
use, and chronic disease are associated with serum hormone concentrations in males (Akishita et 
al. 2010; Allen et al. 2002; Andersson et al. 2007; Dai et al. 1988; Derby et al. 2006; Field et al. 
1994; Gapstur et al. 2002; Gapstur et al. 2007; Haring et al. 2010; Harman et al. 2001; Hautanen 
et al. 1994; Lapauw et al. 2008; Liu et al. 2007; Macdonald et al. 2010; Svartberg et al. 2004; 
Travison et al. 2007; Wu et al. 1995; Yeap et al. 2009), and previous reports of declines in 
testosterone may be related to changing distributions of these factors. In NHANES, the 
magnitudes of decline in testosterone and SHBG in young white men were both diminished after 
excluding men with extreme BMIs, demonstrating that extreme BMIs of the magnitude seen in 
the general US population are prevalent enough to influence estimates of the population mean 
testosterone and SHBG concentrations. It is possible that the difference in results between 
studies is due to the presence of men with extremely high BMIs in some study populations and 
not others. The two studies may also have been influenced by unknown confounders. Differences 
between NHANES and MMAS in how the prevalence of an unknown confounder changed over 
time could have resulted in different amounts of confounding bias in the two studies, resulting in 
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a significant decline in testosterone over time in the MMAS and no significant change in 
NHANES.  
There were significant declines in 3α-diol-G and estradiol in white and Mexican-
American men. Population trends in 3α-diol-G and estradiol have not been studied as extensively 
as testosterone, and to our knowledge there have been no other studies of population trends in 
estradiol or 3α-diol-G concentrations in adult men. Therefore, confirmation of these results in 
other studies is necessary to determine the consistency of these trends in other populations. 
Estradiol and 3α-diol-G are both produced from testosterone by enzymatic conversion. That the 
strong declines in these hormones were seen in the absence of a decline in testosterone suggests 
that the declines are the result of a change in factors affecting the testosterone metabolism 
process. If the estradiol and 3α-diol-G declines are confirmed in other populations, analysis of 
temporal changes in other androgens may help pinpoint which parts of the testosterone 
metabolism pathway are affected.  
Like testosterone, 3α-diol-G and estradiol are associated with anthropometric and 
lifestyle factors. 3α-diol-G concentrations decrease with age and HDL cholesterol (Allen et al. 
2002; Hautanen et al. 1994; Suzuki et al. 2009), and increase with increasing BMI, alcohol use, 
body fat, and visceral adipose tissue (Allen et al. 2002; Tchernof et al. 1997; Wu et al. 2001). 
Estradiol concentrations tend to increase among elderly men (Abbott et al. 2007; Haffner et al. 
1993). Higher estradiol concentrations in middle aged and older men have been associated with 
increased risk of stroke, atrial fibrillation, dementia, and all-cause mortality (Abbott et al. 2007; 
Szulc et al. 2009). The current study was able to control for the effects of some but not all of the 
factors associated with 3α-diol-G and estradiol concentrations; declines in estradiol and 3α-diol-
G persisted after adjustment and after excluding men with extreme BMIs.   
Serum samples from the two NHANES surveys were collected and measured at different 
times, and comparisons may be susceptible to bias from evaporation, assay variation, or other 
unknown factors. We took steps to minimize variation in how the samples were treated, 
including using the same laboratory and same assays to measure testosterone, estradiol, and 
SHBG. Unfortunately, production of the kit used to measure 3α-diol-G in 1988-1991 samples 
was discontinued before the 1999-2004 samples were measured. As a result, the 1999-2004 
samples were measured using a different kit, which was likely responsible for the high variation 
among the 1988-1991 samples measured during the two lab sessions. The CV for 3α-diol-G in 
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1999-2004 samples analyzed in duplicate using the Direct 3α-diol-G kit was 9.7%, indicating 
that the assay itself had an acceptable level of variability. Due to the use of different assays kits 
for the two survey periods, a regression equation was formulated to account for the shift in 
values and to generate adjusted 3α-diol-G concentrations that were used in the statistical 
analysis. Results should be interpreted with the knowledge that although attempts were made to 
correct for the change in assay kits, there may be residual bias in the adjusted values. 
Estradiol measurements displayed unusually high variation for both 1999-2004 
population samples measured in duplicate and for 1988-1991 samples measured during both lab 
sessions, even though the same laboratory method was used for all measurements. The relatively 
low CVs for SHBG and testosterone suggest that variation in estradiol is likely due to assay-
specific rather than serum-specific factors. It is unlikely that this increased variability is driving 
the decline in estradiol concentrations observed among whites and Mexican-Americans. 
Increased assay variability would create a larger spread in the distribution of individual hormone 
values around the mean, and the wider spread would result in more overlap between the 
distributions being compared making it less likely, not more likely, that the distributions would 
be statistically different. Furthermore, if the observed declines were an artifact of the assay we 
would expect to see similar declines in all groups of men; however, no decline was observed 
among black men. Still, the results for estradiol should be interpreted with appropriate caution. 
Analyses in other populations are needed to provide a more accurate estimate of the magnitude 
of the decline. 
NHANES populations are sampled to be representative of the civilian, non-
institutionalized US population. Thus, these results are more generalizable to changes in male 
hormone concentrations that have occurred in the general US population than changes observed 
in individual studies conducted in narrowly-defined populations. The NHANES sampling design 
provided sufficient numbers of participants to estimate hormone concentrations stratified by 
race/ethnicity and age group. Rohrmann et al. (Rohrmann et al. 2007) previously reported that 
there were differences in concentrations of 3α-diol-G, estradiol, and SHBG by race/ethnicity in 
US men, so it was of interest to investigate changes in hormone concentrations within these 
groups as well as in the overall population. We found that some changes in hormone 
concentrations were similar for whites and Mexican-Americans when comparing 1988-1991 and 
1999-2004 surveys, and patterns for blacks were often different from those for whites and 
 14  
Mexican-Americans. Moreover, factors that influence hormone concentrations, such as body 
size, smoking, and alcohol use, vary by demographic factors and geography. Additional analysis 
of demographic factors may be useful in identifying subpopulations in which hormone 
concentrations may be changing over time. 
In conclusion, adjusted mean testosterone concentrations were similar between 1988-
1991 and 1999-2004 in the overall US adult male population. Exploration of the relative 
importance of total testosterone and free testosterone in reproductive health is necessary, as free 
testosterone concentrations were stable in white and Mexican Americans, and may have 
increased in blacks. Adjusted concentrations of 3α-diol-G and estradiol declined in whites and 
Mexican-Americans, but the overall significance of these declines is unknown at this time. 
Examination of these trends and any association with male reproductive conditions in other 
populations would be beneficial.    
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Age 19 or younger 
N=3638 
 
Age 20 and older  
N=4227 
 
Age 20 and older 
N=7223 
Age 19 or younger  
N=7961 
  
 
 
 
 
 
   
 
 
      Home examination N=105 Participated in MEC 
examination 
N=4122 
Participated in MEC 
examination 
N=6735 
Home examination  
N=488 
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Morning examination 
 
Morning examination Afternoon N=2434 
Evening N=768 
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N=3281 Evening N=1020 
  
 
 
 
 
      
    
Organochlorine study 
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No serum 
N=539 
 
Surplus serum available 
N=1470 
 
Surplus serum available 
N=985 
No serum 
N=100 
 
 
 
 
 
 
    
 
 
      Other race N=57 White, black, or Mexican 
American 
N=1413 
White, black, or Mexican 
American 
N=902 
Other race N=67 
Missing or 0 weights N=16 
     
 
 
Table 1. Characteristics of 1988-1991 and 1999-2004 NHANES participants. 
 1988-1991  1999-2004 
  
 Age at interview (years)    Age at interview (years) 
 All 
 20-44 45-69 ≥ 70  All  20-44 45-69 ≥ 70 
N 1413  675 483 255  902  398 342 162 
Median age, years 46  31 57 76  48  32 57 77 
Median BMI, kg/m2 25.8  25.4 26.8 25.8  27.3  26.5 28.5 26.7 
Median waist circumference, cm 94.5  89.5 98.0 99.0  98.8  94.0 103.0 102.2 
Median % bodyfat a 25.9  25.1 26.7 26.8  24.6  24.3 25.4 --- 
Race/ethnicity, N            
White 674  240 244 190  503  187 199 117 
Black 363  202 121 40  183  99 66 18 
Mexican-American 376  233 118 25  216  112 77 27 
Cigarette smoking, %  
 
         
Never smoker 35  44 24 33  41  53 33 33 
Former smoker 35  20 44 57  31  14 37 59 
Current smoker 30  37 32 11  27  33 30 8 
Number of alcohol drinks per 
week, %  
 
         
0 38  24 42 65  30  21 35 45 
less than 1 8  10 7 7  22  23 21 23 
1 to less than 7 28  34 25 15  27  37 21 15 
7 or more  26  31 26 13  20  19 23 17 
a 1999-2004 surveys: percent body fat only measured among those < 50 years old and weighing less than 300 lbs 
 
Table 2. Mean hormone concentrations in adult US males, comparing NHANES 1988-1991 and 1999-2004.  
 1988-1991  1999-2004    
 Meana, b  95% CIc Meana, b 95% CIc Difference    P-value        
Testosterone (ng/ml) 5.37 5.20, 5.53 5.34 5.16, 5.52 -0.03 0.75 
Free testosterone (ng/ml) 0.099 0.094, 0.103 0.097 0.093, 0.103 -0.001 0.67 
SHBG (nmol/L) 34.71 33.36, 36.12 33.54 32.10, 35.04 -1.17 0.19 
3α-diol-G (ng/ml) 11.98 11.41, 12.58 10.15 9.72, 10.60 -1.83 <0.01 
Estradiol (pg/ml) 35.74 34.25, 37.29 29.67 28.20, 31.20 -6.07 <0.01 
a adjusted for age (1 year intervals), race/ethnicity, BMI, waist circumference, smoking, and alcohol use 
b means for free testosterone, SHBG, 3α-diol-G, and estradiol are geometric means 
c CI – confidence interval 
 
Table 3. Difference in mean hormone concentrations by age group, comparing NHANES 1988-1991 to 1999-2004. 
 
 1988-1991  1999-2004    
 
Age  Meana, b  95% CIc Meana, b  95% CIc Difference P-value 
Testosterone (ng/ml)  20-44 5.49 5.25, 5.73 5.29 5.03, 5.55 -0.20 0.15 
  45-69 5.20 4.95, 5.45 5.38 5.10, 5.67 0.18 0.21 
  ≥ 70 5.15 4.64, 5.67 5.34 4.77, 5.91 0.19 0.39 
        
Free testosterone (ng/ml)  20-44 0.102 0.096, 0.108 0.103 0.097, 0.109 0.001 0.67 
  45-69 0.098 0.089, 0.109 0.095 0.088, 0.103 -0.003 0.55 
  ≥ 70 0.083 0.071, 0.097 0.073 0.060, 0.089 -0.010 0.19 
        
SHBG (nmol/L)  20-44 35.75 33.38, 38.29 31.69 29.62, 33.90 -4.06 <0.01 
  45-69 32.56 30.01, 35.32 35.19 32.17, 38.50 2.64 0.04 
  ≥ 70 35.54 30.07, 42.01 38.35 32.79, 44.85 2.81 0.13 
        
3α-diol-G (ng/ml)  20-44 12.29 11.40, 13.26 9.80 9.13, 10.52 -2.49 <0.01 
  45-69 11.38 10.14, 12.77 10.45 9.56, 11.43 -0.92 0.15 
  ≥ 70 12.09 9.85, 14.85 10.98 9.21, 13.08 -1.11 0.20 
        
Estradiol (pg/ml)  20-44 35.53 33.70, 37.47 29.45 27.45, 31.60 -6.08 <0.01 
  45-69 35.36 32.34, 38.67 29.95 27.74, 32.34 -5.41 <0.01 
  ≥ 70 38.61 34.23, 43.56 29.98 25.59, 35.13 -8.63 <0.01 a adjusted for age, race/ethnicity (1 year intervals), BMI, waist circumference, smoking, and alcohol use 
b means for free testosterone, SHBG, 3α-diol-G, and estradiol are geometric means 
c CI – confidence interval 
 
Table 4. Difference in mean hormone concentrations by race/ethnicity, comparing NHANES 1988-1991 to 1999-2004.  
 Race/ ethnicity 1988-1991  1999-2004    
 Meana, b  95% CIc Meana, b  95% CIc Difference P-value 
Testosterone (ng/ml)  White 5.38 5.20, 5.56 5.28 5.08, 5.49 -0.10 0.37 
  Black 5.33 4.97, 5.69 5.90 5.55, 6.26 0.57 0.02 
  Mexican-American 5.29 5.12, 5.46 5.09 4.76, 5.43 -0.20 0.26 
        
Free testosterone (ng/ml)  White 0.099 0.094, 0.104 0.096 0.091, 0.102 -0.003 0.45 
  Black 0.096 0.089, 0.104 0.107 0.098, 0.117 0.011 0.04 
  Mexican-American 0.099 0.095, 0.104 0.095 0.088, 0.102 -0.005 0.23 
        
SHBG (nmol/L)  White 34.87 33.37, 36.43 33.42 31.79, 35.13 -1.45 0.15 
  Black 34.37 32.22, 36.66 34.47 31.72, 37.45 0.10 0.95 
  Mexican-American 33.11 31.42, 34.88 33.24 30.75, 35.93 0.13 0.93 
        
3α-diol-G (ng/ml)  White 12.22 11.55, 12.92 10.16 9.64, 10.71 -2.06 <0.01 
  Black 10.90 10.02, 11.85 10.25 9.57, 10.99 -0.65 0.24 
  Mexican-American 10.73 9.96, 11.57 9.57 8.82, 10.37 -1.17 0.03 
        
Estradiol (pg/ml)  White 35.41 33.76, 37.14 28.94 27.34, 30.63 -6.47 <0.01 
  Black 40.15 38.17, 42.22 38.94 34.88, 43.47 -1.21 0.61 
  Mexican-American 33.41 31.03, 35.97 26.14 23.97, 28.51 -7.27 <0.01 a adjusted for age (1 year intervals), BMI, waist circumference, smoking, and alcohol use  
b means for free testosterone, SHBG, 3α-diol-G, and estradiol are geometric means 
c CI – confidence interval 
 
Table 5. Difference in mean hormone concentrations by age and race/ethnicity, comparing NHANES 1988-1991 to 1999-2004.  
  1988-1991  1999-2004  
  
 Age (years) Meana, b  95% CIc Meana, b  95% CIc Difference P-value 
White 
       
Testosterone (ng/ml)  20-44  5.51 5.26, 5.76 5.20 4.90, 5.51 -0.31 0.06 
  45-69  5.19 4.93, 5.45 5.35 5.04, 5.67 0.17 0.30 
  ≥ 70  5.21 4.70, 5.72 5.25 4.66, 5.84 0.04 0.85 
 
       
Free testosterone (ng/ml)  20-44  0.102 0.096, 0.109 0.102 0.096, 0.108 0 0.93 
  45-69  0.098 0.088, 0.110 0.095 0.087, 0.104 -0.003 0.61 
  ≥ 70  0.084 0.072, 0.097 0.070 0.057, 0.087 -0.014 0.09 
 
       
SHBG (nmol/L)  20-44  36.07 33.56, 38.77 30.94 28.54, 33.53 -5.14 <0.01 
  45-69  32.47 29.87, 35.28 35.29 31.99, 38.93 2.83 0.05 
  ≥ 70  36.12 30.40, 42.90 39.16 33.11, 46.32 3.04 0.13 
 
       
3α-diol-G (ng/ml)  20-44  12.57 11.59, 13.64 9.68 8.88, 10.55 -2.89 <0.01 
  45-69  11.57 10.26, 13.06 10.60 9.59, 11.71 -0.97 0.17 
  ≥ 70  12.32 10.09, 15.05 10.79 9.03, 12.89 -1.53 0.08 
 
       
Estradiol (pg/ml)  20-44  35.14 33.11, 37.29 28.65 26.31, 31.19 -6.49 <0.01 
  45-69  35.09 31.92, 38.58 29.37 26.96, 32.00 -5.72 <0.01 
  ≥ 70  38.46 34.02, 43.48 28.96 24.48, 34.27 -9.50 <0.01 
 
       
Black 
       
Testosterone (ng/ml)  20-44  5.42 4.94, 5.91 5.97 5.55, 6.39 0.55 0.06 
  45-69  5.37 4.82, 5.92 5.74 5.07, 6.42 0.38 0.37 
  ≥ 70  4.41 3.55, 5.28 6.26 4.14, 8.39 1.85 0.09 
 
       
Free testosterone (ng/ml)  20-44  0.098 0.089, 0.107 0.112 0.101, 0.124 0.014 0.03 
  45-69  0.102 0.090, 0.115 0.101 0.088, 0.115 -0.001 0.87 
  ≥ 70  0.069 0.048, 0.099 0.104 0.078, 0.137 0.035 0.05 
 
       
SHBG (nmol/L)  20-44  35.21 32.02, 38.72 34.94 31.69, 38.52 -0.27 0.88 
  45-69  33.08 29.71, 36.84 34.34 29.36, 40.17 1.26 0.64 
  ≥ 70  30.46 25.69, 36.11 29.98 23.81, 37.75 -0.48 0.88 
  1988-1991  1999-2004  
  
 Age (years) Meana, b  95% CIc Meana, b  95% CIc Difference P-value 
 
       
3α-diol-G (ng/ml)  20-44  11.16 9.99, 12.46 10.16 9.24, 11.17 -1.00 0.15 
  45-69  10.54 8.19, 13.55 10.00 8.79, 11.37 -0.54 0.68 
  ≥ 70  9.77 6.91, 13.82 13.97 8.36, 23.36 4.20 0.19 
 
       
Estradiol (pg/ml)  20-44  40.67 38.30, 43.18 38.97 34.31, 44.25 -1.70 0.54 
  45-69  38.75 35.52, 42.26 38.03 31.58, 45.78 -0.72 0.84 
  ≥ 70  39.53 32.90, 47.49 44.41 31.62, 62.38 4.89 0.51 
 
       
Mexican American      
 Testosterone (ng/ml)  20-44  5.36 5.12, 5.60 5.07 4.65, 5.50 -0.28 0.16 
  45-69  5.15 4.80, 5.49 5.16 4.44, 5.88 0.01 0.97 
  ≥ 70  5.52 4.51, 6.52 5.80 5.00, 6.60 0.28 0.62 
 
       
Free testosterone (ng/ml)  20-44  0.104 0.099, 0.109 0.100 0.091, 0.109 -0.004 0.40 
  45-69  0.094 0.086, 0.103 0.086 0.073, 0.101 -0.009 0.26 
  ≥ 70  0.104 0.086, 0.124 0.100 0.085, 0.117 -0.003 0.72 
 
       
SHBG (nmol/L)  20-44  32.76 29.94, 35.85 32.54 29.20, 36.25 -0.23 0.90 
  45-69  33.98 31.41, 36.77 34.94 29.32, 41.65 0.96 0.75 
  ≥ 70  32.33 26.43, 39.54 35.99 29.45, 43.98 3.66 0.35 
 
       
3α-diol-G (ng/ml)  20-44  10.84 9.63, 12.21 9.57 8.54, 10.72 -1.27 0.09 
  45-69  9.88 8.52, 11.45 9.24 8.05, 10.60 -0.64 0.48 
  ≥ 70  14.87 9.71, 22.77 12.07 10.17, 14.33 -2.79 0.33 
 
       
Estradiol (pg/ml)  20-44  33.38 30.92, 36.03 25.88 23.47, 28.52 -7.50 <0.01 
  45-69  32.31 28.69, 36.38 26.21 22.83, 30.10 -6.10 0.02 
  ≥ 70  37.93 31.13, 46.21 28.61 23.38, 35.02 -9.32 0.01 
a adjusted for age (1 year intervals), BMI, waist circumference, smoking, and alcohol use  
b means for free testosterone, SHBG, 3α-diol-G, and estradiol are geometric means 
c CI – confidence interval 
 
Supplementary table 1. Difference in mean hormone concentrations with adjustment for age and race/ethnicity only, comparing NHANES 1988-1991 to 1999-
2004. 
  1988-1991  1999-2004    
  Mean 
a  95% CI b Mean a  95% CI b Difference P –value 
Testosterone (ng/mL)  5.47 5.31, 5.64 5.08 4.90, 5.25 -0.40 <0.01 
Free testosterone (ng/mL)  0.100 0.096, 0.104 0.094 0.089, 0.098 -0.006 0.02 
SHBG (nmol/L)  35.68 34.18, 37.25 32.00 30.47, 33.61 -3.68 <0.01 
3α-diol-G (ng/mL)  11.87 11.26, 12.51 10.25 9.78, 10.73 -1.62 <0.01 
Estradiol (pg/mL)  35.59 34.13, 37.12 30.02 28.53, 31.58 -5.58 <0.01 
a adjusted for age (1-year intervals) and race/ethnicity 
b CI – confidence interval 
 
  
Supplementary table 2. Difference in mean hormone concentrations by age group with adjustment for age and race/ethnicity only, comparing NHANES 1988-1991 to 
1999-2004. 
  1988-1991  1999-2004    
 Age years Mean 
a  95% CI b Mean a  95% CI b Difference P –value 
Testosterone (ng/mL)  20-44 5.42 5.13, 5.72 4.93 4.60, 5.25 -0.49 <0.01 
  45-69 5.47 5.21, 5.74 5.18 4.86, 5.49 -0.29 0.07 
  70+ 5.76 5.18, 6.34 5.63 5.02, 6.24 -0.13 0.47 
Free testosterone (ng/mL)  20-44 0.101 0.095, 0.107 0.098 0.093, 0.104 -0.003 0.37 
  45-69 0.101 0.092, 0.111 0.092 0.085, 0.099 -0.009 0.05 
  70+ 0.088 0.076, 0.102 0.075 0.061, 0.092 -0.013 0.07 
SHBG (nmol/L)  20-44 35.37 32.82, 38.11 29.41 27.04, 31.98 -5.96 <0.01 
  45-69 34.61 31.78, 37.69 34.00 30.86, 37.45 -0.62 0.67 
  70+ 41.24 34.50, 49.29 42.21 35.42, 50.30 0.97 0.65 
3α-diol-G (ng/mL)  20-44 12.07 11.20, 13.01 9.67 8.98, 10.40 -2.40 <0.01 
  45-69 11.42 10.26, 12.70 10.86 9.93, 11.88 -0.56 0.38 
  70+ 12.03 9.93, 14.57 11.30 9.47, 13.49 -0.73 0.40 
Estradiol (pg/mL)  20-44 35.23 33.27, 37.31 29.42 27.40, 31.59 -5.81 <0.01 
  45-69 35.60 32.56, 38.92 31.08 28.68, 33.68 -4.51 <0.01 
  70+ 37.99 33.49, 43.10 29.24 25.02, 34.18 -8.75 <0.01 
       a adjusted for age (1-year intervals) and race/ethnicity 
b CI – confidence interval 
 
  
Supplementary table 3. Difference in mean hormone concentrations by race/ethnicity with adjustment for age only, comparing NHANES 1988-1991 to 1999-2004. 
  1988-1991  1999-2004    
 Race/ethnicity Mean 
a  95% CI b Mean a  95% CI b Difference P –value 
Testosterone (ng/mL)  White 5.45 5.27, 5.64 4.96 4.75, 5.17 -0.49 <0.01 
  Black 5.71 5.40, 6.03 5.99 5.58, 6.40 0.27 0.28 
  Mexican-American 5.30 5.16, 5.44 4.98 4.63, 5.33 -0.32 0.09 
Free testosterone (ng/mL)  White 0.100 0.095, 0.104 0.092 0.087, 0.097 -0.007 0.01 
  Black 0.100 0.092, 0.108 0.106 0.097, 0.115 0.006 0.28 
  Mexican-American 0.099 0.095, 0.102 0.093 0.087, 0.100 -0.006 0.10 
SHBG (nmol/L)  White 35.66 33.99, 37.42 31.45 29.72, 33.28 -4.21 <0.01 
  Black 37.17 35.53, 38.89 35.61 32.65, 38.84 -1.57 0.38 
  Mexican-American 33.31 31.71, 35.00 32.63 29.79, 35.74 -0.68 0.68 
3α-diol-G (ng/mL)  White 12.16 11.45, 12.92 10.33 9.76, 10.92 -1.84 <0.01 
  Black 10.32 9.54, 11.16 9.98 9.35, 10.65 -0.34 0.51 
  Mexican-American 10.91 10.20, 11.66 9.57 8.91, 10.29 -1.33 0.01 
Estradiol (pg/mL)  White 35.21 33.49, 37.01 29.36 27.66, 31.16 -5.85 <0.01 
  Black 40.73 39.04, 42.49 38.65 34.95, 42.75 -2.08 0.34 
 Mexican-American 32.81 30.89, 34.84 26.16 23.80, 28.75 -6.65 <0.01 a adjusted for age (1-year intervals) 
b CI – confidence interval 
 
  
Supplementary table 4. Difference in mean hormone concentrations comparing NHANES 1988-1991 to 1999-2004 by race/ethnicity and age, with adjustment for age 
only. 
  1988-1991  1999-2004    
White  Mean 
a  95% CI b Mean a  95% CI b Difference P-value 
Testosterone (ng/mL)  20-44  5.42 5.10, 5.74 4.76 4.36, 5.16 -0.66 <0.01 
  45-69  5.41 5.12, 5.70 5.10 4.73, 5.46 -0.31 0.09 
  ≥ 70  5.81 5.23, 6.38 5.53 4.91, 6.15 -0.28 0.14 
        
Free testosterone (ng/mL)  20-44  0.101 0.094, 0.108 0.097 0.091, 0.102 -0.004 0.17 
  45-69  0.101 0.091, 0.111 0.091 0.083, 0.100 -0.009 0.09 
  ≥ 70  0.089 0.077, 0.103 0.073 0.058, 0.090 -0.016 0.04 
        
SHBG (nmol/L)  20-44  35.62 32.86, 38.61 28.28 25.58, 31.26 -7.34 <0.01 
  45-69  34.13 31.24, 37.29 33.69 30.30, 37.45 -0.45 0.77 
  ≥ 70  41.73 34.76, 50.09 42.73 35.49, 51.45 1.00 0.67 
        
3α-diol-G (ng/mL)  20-44  12.39 11.42, 13.45 9.57 8.73, 10.48 -2.83 <0.01 
  45-69  11.69 10.45, 13.09 11.09 10.02, 12.28 -0.60 0.40 
  ≥ 70  12.33 10.24, 14.85 11.25 9.43, 13.42 -1.08 0.22 
        
Estradiol (pg/mL)  20-44  34.82 32.65, 37.14 28.59 26.16, 31.24 -6.24 <0.01 
  45-69  35.23 31.99, 38.81 30.67 28.03, 33.55 -4.57 0.01 
  ≥ 70  37.69 33.06, 42.97 28.33 24.00, 33.44 -9.36 <0.01 
        
Black        
Testosterone (ng/mL)  20-44  5.56 5.07, 6.05 5.95 5.41, 6.49 0.40 0.23 
  45-69  6.17 5.66, 6.67 5.93 5.28, 6.58 -0.24 0.55 
  ≥ 70  5.11 4.31, 5.91 6.43 4.22, 8.65 1.33 0.23 
        
Free testosterone (ng/mL)  20-44  0.100 0.091, 0.110 0.111 0.099, 0.123 0.011 0.10 
  45-69  0.110 0.099, 0.122 0.101 0.089, 0.113 -0.009 0.23 
  ≥ 70  0.074 0.054, 0.102 0.094 0.064, 0.139 0.020 0.32 
        
SHBG (nmol/L)  20-44  35.79 32.93, 38.91 34.82 31.23, 38.82 -0.97 0.64 
  45-69  39.37 35.27, 43.94 36.26 30.93, 42.51 -3.11 0.34 
  ≥ 70  36.77 30.05, 45.00 35.73 27.35, 46.68 -1.04 0.82 
        
3α-diol-G (ng/mL)  20-44  10.50 9.35, 11.79 9.83 9.03, 10.70 -0.67 0.29 
  45-69  10.02 8.04, 12.49 9.81 8.74, 11.02 -0.21 0.85 
  ≥ 70  9.44 6.84, 13.02 12.79 7.20, 22.73 3.35 0.30 
        
Estradiol (pg/mL)  20-44  40.59 38.11, 43.22 38.73 34.34, 43.68 -1.85 0.47 
  45-69  40.50 37.45, 43.81 37.70 31.55, 45.05 -2.80 0.42 
  ≥ 70  41.33 34.66, 49.27 41.83 30.17, 57.99 0.51 0.94 
        
Mexican-American       
Testosterone (ng/mL)  20-44  5.25 5.01, 5.50 4.84 4.39, 5.30 -0.41 0.05 
  45-69  5.13 4.73, 5.52 5.05 4.29, 5.81 -0.08 0.85 
  ≥ 70  6.04 5.05, 7.03 6.07 5.35, 6.80 0.03 0.95 
        
Free testosterone (ng/mL)  20-44  0.102 0.097, 0.108 0.097 0.089, 0.106 -0.005 0.21 
  45-69  0.094 0.086, 0.102 0.086 0.074, 0.099 -0.008 0.25 
  ≥ 70  0.108 0.092, 0.128 0.103 0.088, 0.120 -0.006 0.56 
        
SHBG (nmol/L)  20-44  31.92 29.44, 34.61 30.94 27.39, 34.94 -0.98 0.61 
  45-69  34.32 31.77, 37.06 34.62 28.68, 41.79 0.31 0.93 
  ≥ 70  36.55 29.70, 44.98 38.30 31.75, 46.18 1.75 0.68 
        
3α-diol-G (ng/mL)  20-44  10.98 9.89, 12.20 9.40 8.48, 10.42 -1.58 0.02 
  45-69  9.94 8.64, 11.44 9.61 8.53, 10.82 -0.34 0.70 
  ≥ 70  14.36 9.96, 20.70 12.01 10.30, 14.00 -2.35 0.34 
        
Estradiol (pg/mL)  20-44  32.51 30.01, 35.23 25.76 23.07, 28.76 -6.76 <0.01 
  45-69  32.29 29.64, 35.17 26.60 23.17, 30.54 -5.69 0.01 
  ≥ 70  37.09 31.04, 44.33 27.72 22.75, 33.77 -9.38 0.01 a adjusted for age (1-year intervals)  
b CI – confidence interval 
 
 
 
 
  
Supplementary table 5. Difference in NHANES 1988-1991 and 1999-2004 mean hormone concentrations among white men ages 20-44 years, restricting to subjects 
with BMI within the 5th and 95th percentilesa. 
 Difference
b, c    P-value        
Testosterone (ng/mL) -0.15 0.38 
Free testosterone (ng/mL) -0.002 0.70 
SHBG (nmol/L) -2.20 0.10 
3α-diol-G (ng/mL) -3.45 < 0.01 
Estradiol (pg/mL) -7.08 < 0.01 
a BMI greater than 20.4 kg/m2 and less than 36.6 kg/m2 
b adjusted for age (1-year intervals), BMI, waist circumference, smoking, and alcohol use 
c differences for free testosterone, SHBG, 3α-diol-G, and estradiol were calculated from geometric means  
 
 
 
 
  
Supplementary table 6. Difference in NHANES 1988-1991 and 1999-2004 mean hormone concentrations among black men, restricting to subjects with BMI within 
the 5th and 95th percentilesa. 
 Difference
b, c    P-value        
Testosterone (ng/mL) 0.60 0.02 
Free testosterone (ng/mL) 0.012 0.08 
SHBG (nmol/L) 0.42 0.81 
3α-diol-G (ng/mL) -0.74 0.18 
Estradiol (pg/mL) -1.07 0.67 
a BMI greater than 19.2 kg/m2 and less than 37.6 kg/m2 
b adjusted for age (1-year intervals), BMI, waist circumference, smoking, and alcohol use 
c differences for free testosterone, SHBG, 3α-diol-G, and estradiol were calculated from geometric means 
 
Supplementary figure. Flow chart of how analytic populations were sampled from the full 
NHANES survey populations. Analytic populations were limited to men, aged 20 years or older, 
who participated in morning examinations at the mobile examination center (MEC), and were 
white, black, or Mexican American. 
